Find all Leading Research Universities Reports below. The Leading Research Universities report is a free newsletter covering events in higher education and research.

The approach offers an alternative to the existing facilities and administrative (F&A) cost reimbursement system by which the federal government reimburses universities for certain essential costs of conducting research on behalf of the American people.
Costs of Research (F&A Costs) | Leading Research Universities Report | Research Administration & Regulation

A recent report from the National Academies of Sciences, Engineering, and Medicine (NASEM) emphasizes the need for immediate, system-wide change to reduce regulatory burdens on research.
Reducing Regulatory Burden | Leading Research Universities Report | Higher Education Regulation | Research Administration & Regulation

DHS and ICE have proposed a rule that would make it harder for international students to complete their degree programs in the United States, obtain practical work experience upon graduation, or move on to another degree level.

An effort by the administration to expand the collection and reporting of college admissions data raises serious questions about whether it's practical and how the data will be used.

Later this month, the 14th annual Golden Goose Award will honor four scientists whose curiosity-driven, federally funded research led to major scientific breakthroughs.

The House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies advanced its FY26 spending bill last week along party lines.

On August 7, President Trump issued an executive order that greatly weakens merit-based processes for reviewing applications for federal research funding by transferring final decision-making authority from scientific experts to political appointees.

In a brief, the associations asserted that the administration’s blanket cancellation of NIH grants for ideological reasons flouts longstanding principles of science-based decision-making.

A permanent 10% reduction in federal funding for the National Institutes of Health would lead to fewer drugs coming to market, finds a new analysis by the Congressional Budget Office.

The United States remained the world’s largest research and development (R&D) enterprise in 2023, according to a new report from the National Science Board.